z-logo
Premium
Prospective study of infectious complications in a cohort of pediatric renal transplant recipients
Author(s) -
MartínPeña Almudena,
Cordero Elisa,
Fijo Julia,
SánchezMoreno Ana,
MartínGovantes Juan,
Torrubia Francisco,
Cisneros José
Publication year - 2009
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/j.1399-3046.2008.01019.x
Subject(s) - medicine , incidence (geometry) , prospective cohort study , etiology , cohort , transplantation , risk factor , cohort study , kidney transplantation , pediatrics , physics , optics
  Infections are frequent and serious in pediatric RT recipients; however, the information available is scarce. The aim of this study was to determine the incidence, etiology, and risk factors for infection in these patients. This was a prospective, observational study of a consecutive pediatric RT recipient cohort. Risk factors for infection and descriptive analyses during the first two post‐transplantation years were performed. Twenty‐one patients (58.3%) had at least one infection (incidence 1.5 episodes/patient/first year of transplantation). There were 33 bacterial infections (73.3%), 11 viral infections (24.4%), and one protozoal infection. UTI was the most common syndrome (48.3%), followed by CMV infection (15.5%). The main microorganisms isolated were Escherichia coli (28.9%), 46.1% of which were ESBL producers, and CMV (20%). Patient and graft survival at the end of follow‐up were 97.2% and 83.3%, respectively. The only risk factor for infection was cold ischemia time >800 min (OR 5.7, CI 95% 1.7–19.3). Conclusions: In pediatric RT recipients, UTI is the most frequent syndrome. Bacterial infections are the most common, with a high rate of ESBL producer strains. Despite their good prognosis, infections are a cause of morbidity that could potentially be reduced by decreasing cold ischemia times.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here